Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting

被引：6
作者：
Kim, Hyun Jung [1 ,2 ,3 ]
机构：
[1] Kookmin Univ, Dept Biopharmaceut Chem, Seoul 02707, South Korea
[2] Kookmin Univ, Sch Appl Chem, Seoul 02707, South Korea
[3] Kookmin Univ, Antibody Res Inst, Seoul 02707, South Korea
来源：
MEDICINA-LITHUANIA | 2022年 / 58卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
hepatocyte growth factor; c-MET; ovarian cancer; humanized monoclonal antibody; anti-cancer; therapeutics; HEPATOCYTE GROWTH-FACTOR; RECURRENT EPITHELIAL OVARIAN; RECEPTOR TYROSINE KINASE; PHASE-II EVALUATION; C-MET; SCATTER FACTOR; FALLOPIAN-TUBE; MESENCHYMAL TRANSITION; FACTOR/SCATTER FACTOR; CLINICAL-SIGNIFICANCE;
D O I：
10.3390/medicina58050649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ovarian cancer is the fifth leading cause of cancer deaths in women and is regarded as one of the most difficult cancers to treat. Currently, studies are being conducted to develop therapeutic agents for effective treatment of ovarian cancer. In this review, we explain the properties of the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (c-MET) and how the signaling pathway of HGF/c-MET is activated in different cancers and involved in tumorigenesis and metastasis of ovarian cancer. We present the findings of clinical studies using small chemicals or antibodies targeting HGF/c-MET signaling in various cancer types, particularly in ovarian cancer. We also discuss that HGF/c-MET-targeted therapy, when combined with chemo drugs, could be an effective strategy for ovarian cancer therapeutics.
引用
收藏
页数：12
相关论文
共 108 条
[91]   Cancer Statistics, 2021 [J].
Siegel, Rebecca L. ;
Miller, Kimberly D. ;
Fuchs, Hannah E. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (01) :7-33
[92]   SCATTER FACTOR IS A FIBROBLAST-DERIVED MODULATOR OF EPITHELIAL-CELL MOBILITY [J].
STOKER, M ;
GHERARDI, E ;
PERRYMAN, M ;
GRAY, J .
NATURE, 1987, 327 (6119) :239-242
[93]   HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model [J].
Suarez-Causado, A. ;
Caballero-Diaz, D. ;
Bertran, E. ;
Roncero, C. ;
Addante, A. ;
Garcia-Alvaro, M. ;
Fernandez, M. ;
Herrera, B. ;
Porras, A. ;
Fabregat, I. ;
Sanchez, A. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (10) :2453-2463
[94]   CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results [J].
Szubert, Maria ;
Suzin, Jacek ;
Wierzbowski, Tomasz ;
Kowalczyk-Amico, Katarzyna .
ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) :504-508
[95]   Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice [J].
Tao, X. ;
Hill, K. S. ;
Gaziova, I. ;
Sastry, S. K. ;
Qui, S. ;
Szaniszlo, P. ;
Fennewald, S. ;
Resto, V. A. ;
Elferink, L. A. .
ORAL ONCOLOGY, 2014, 50 (02) :104-112
[96]   Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial [J].
Trimbos, JB ;
Vergote, I ;
Bolis, G ;
Vermorken, JB ;
Mangioni, C ;
Madronal, C ;
Franchi, M ;
Tateo, S ;
Zanetta, G ;
Scarfone, G ;
Giurgea, L ;
Timmers, P ;
Coens, C ;
Pecorelli, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (02) :113-125
[97]   Function and interactions of integrins [J].
van der Flier, A ;
Sonnenberg, A .
CELL AND TISSUE RESEARCH, 2001, 305 (03) :285-298
[98]  
van Haaften-Day C, 2001, CANCER-AM CANCER SOC, V92, P2837, DOI 10.1002/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO
[99]  
2-5
[100]   Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma [J].
Wang, Huimin ;
Tan, Mingzi ;
Zhang, Song ;
Li, Xiao ;
Gao, Jian ;
Zhang, Danye ;
Hao, Yingying ;
Gao, Song ;
Liu, Juanjuan ;
Lin, Bei .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (02) :3391-3404
234567891011